A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis

J Psychoactive Drugs. 2022 Sep-Oct;54(4):319-323. doi: 10.1080/02791072.2021.2006373. Epub 2021 Nov 28.

Abstract

Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.

Keywords: 2-fluorodeschloroketamine; Novel psychoactive substances; ketamine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Emergency Service, Hospital
  • Humans
  • Ketamine* / adverse effects
  • Male
  • Psychotropic Drugs / adverse effects
  • Substance-Related Disorders*

Substances

  • Ketamine
  • Psychotropic Drugs